Enh3ance trial results indicate DTX301 reduces ammonia levels by 18% and supports dietary liberalization in patients with OTC deficiency.
ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced that Phase 1b data for IBC-Ab002, a newly engineered ...
Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...
WEST PALM BEACH, FL / ACCESS Newswire / March 12, 2026 / The Longevity Centers of America (LCOA) has expanded its mental ...
ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced that Phase 1b data for IBC-Ab002, a newly engineered ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...
Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...
WEST PALM BEACH, FL / ACCESS Newswire / March 12, 2026 / The Longevity Centers of America (LCOA) has expanded its mental wellness offerings with Procaine IV Therapy. This integrative treatment support ...
Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.
The Challenge of Post-Sternotomy Pain Managing post-sternotomy pain is a critical concern for adults undergoing cardiac surgery. Severe pain after a median sternotomy can hinder breathing, ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results